Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study
Multiple Sclerosis Journal · 2024-05 · 30 (6) · 747-750
DOI: 10.1177/13524585241230236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 19.02.2024. Verfasst von Marco Rovaris und 12 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milano, Italy. Hauptthemen laut MEDLINE: Eye Movement Desensitization Reprocessing, Multiple Sclerosis, Depression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: EMDR Europe Association.
Abstract (Originalsprache)
Background
Multiple studies have highlighted elevated rates of depression among individuals with Multiple Sclerosis (MS), with its associated symptoms posing a significant threat to overall well-being. Moreover, existing literature suggests a potential interconnection between depressive manifestations and the decline of physical functionalities in the context of MS. Objective: to examine the viability of the Eye Movement Desensitization Reprocessing (EMDR) therapy protocol for the treatment of depressive disorders (DeprEND) for alleviating depression in individuals with MS.
Methods
We conducted a process–outcome study to examine the feasibilty and effectiveness DeprEND enrolling 13 individuals with MS and depressive symtpoms. Psychological and physical assessment pre-, post-intervention and 3-month follow-up were included. Pre- and post-magnetic resonance imaging (MRI) scans were conducted to analyze potential alterations in brain function.
Results
The EMDR DeprEND treatment showed a high level of adherence and feasibility. Significant reductions in depressive symptoms were found at post-intervention and at 3 months follow-up. No significant differences were observed in terms of physical symptoms. A significant modulation observed in parietal and premotor areas when examining negative valence stimuli post-treatment was found. Conclusion: for The EMDR DeprEND protocol may represent a feasible and cost-effective treatment for reducing depressive symptoms in MS patients and improving their mental well-being.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milano, Italy.
- Department of Psychology, Università Cattolica del Sacro Cuore, Milano, Italy.
- Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
- CRSP, Centro di Ricerca e Studi in Psicotraumatologia, Milano, Italy.
ORCID-Profile: Marco Rovaris, Sonia Di Tella, Francesco Pagnini, Cesare Cavalera
Förderung
- EMDR Europe Association
Zitieren
APA
Rovaris, M., Toselli, E., Mendozzi, L., Di Tella, S., Pirastru, A., Blasi, V., Baglio, F., Ostacoli, L., D'Abramo, A., Incerti, A., Fernandez, I., Pagnini, F., & Cavalera, C. (2024). Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study. Multiple Sclerosis Journal, 30(6), 747-750. https://doi.org/10.1177/13524585241230236
Vancouver
Rovaris M, Toselli E, Mendozzi L, Di Tella S, Pirastru A, Blasi V, et al. Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study. Multiple Sclerosis Journal. 2024;30(6):747-750. doi:10.1177/13524585241230236
BibTeX
@article{Rovaris2024,
author = {Rovaris, Marco and Toselli, Elena and Mendozzi, Laura and Di Tella, Sonia and Pirastru, Alice and Blasi, Valeria and Baglio, Francesca and Ostacoli, Luca and D'Abramo, Alessandra and Incerti, Alessia and Fernandez, Isabel and Pagnini, Francesco and Cavalera, Cesare},
title = {Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study},
journal = {Multiple Sclerosis Journal},
year = {2024},
volume = {30},
number = {6},
pages = {747--750},
doi = {10.1177/13524585241230236}
}
EUVIMED